Handelsbanken Fonder’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-16,100
Closed -$180K 1603
2023
Q1
$180K Hold
16,100
﹤0.01% 1471
2022
Q4
$136K Buy
+16,100
New +$153K ﹤0.01% 1487
2022
Q2
Sell
-9,100
Closed -$226K 1661
2022
Q1
$226K Hold
9,100
﹤0.01% 1608
2021
Q4
$292K Sell
9,100
-5,000
-35% -$183K ﹤0.01% 1619
2021
Q3
$507K Buy
14,100
+4,000
+40% +$157K ﹤0.01% 1357
2021
Q2
$446K Buy
+10,100
New +$440K ﹤0.01% 1462

Other funds holding LUNG

Handelsbanken Fonder's LUNG Position: Q2 2023 in Review

Handelsbanken Fonder sold out of Pulmonx (LUNG) in Q2 2023, closing a stake of 16,100 shares — an estimated $180K sold.

Handelsbanken Fonder first reported a position in LUNG in Q2 2021 and held it in 6 quarters. The position peaked at $507K in Q3 2021. 115 funds tracked by Wall St. Rank hold LUNG as of Q2 2023.

  • Handelsbanken Fonder reported no remaining Pulmonx position as of Q2 2023 after selling out during the quarter.
  • Handelsbanken Fonder sold 16,100 Pulmonx shares in Q2 2023, an estimated $180K.
  • Handelsbanken Fonder first reported a position in Pulmonx in Q2 2021 and held it in 6 quarters.
  • Handelsbanken Fonder's Pulmonx position peaked at $507K in Q3 2021.
  • 115 funds tracked by Wall St. Rank held Pulmonx as of Q2 2023.

Based on Handelsbanken Fonder's 13F filing for Q2 2023, filed 2 Aug 2023.